Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2026-01-22 @ 11:51 PM
Study NCT ID:
NCT07154368
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-09-19
First Post:
2025-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.
Sponsor:
Guangzhou JOYO Pharma Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
JYP0322M302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None